ZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs Monitor
ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today the receipt of a sole source contract from the Defense Logistics Agency to supply Propaq® M deployable vital signs monitors to the U.S. Air Force and the U.S. Army.
The Propaq M, selected as the joint “Product of Choice,” is an advanced vital signs transport monitor, with capabilities far beyond the Propaq Encore 206, which has been the tried and trusted vital signs monitor serving the U.S. military over the last 25 years.
The Propaq M was designed specifically for the rigors of military operations in the most austere environments. The Propaq M can be equipped with an integrated defibrillator and pacer for critical lifesaving mission readiness. This configuration, known as the Propaq MD, eliminates the need to carry a separate monitor and defibrillator to improve operational efficiencies. During the competitive evaluation period, military subject matter experts stressed the importance of printing the 12 Lead ECG report and related patient data directly from the vital signs monitor. The Propaq M is the only airworthy vital signs monitor that is available with an integrated printer, thereby allowing the services to reduce size, weight and cube by eliminating the need to carry a separate standalone printer.
“We are very pleased to see the continued commitment to the ZOLL Propaq platform,” said A. Ernest Whiton, President of ZOLL’s global Resuscitation division. “This recent award demonstrates the DoD’s confidence in ZOLL’s monitoring and monitoring/defibrillation technology that is currently deployed throughout the services today.”
The Propaq M now joins several other ZOLL airworthy products selected by the services as their standard critical care transport medical device, further enhancing Defense Healthcare’s goal for interoperability throughout all roles of care in the U.S. Navy, the U.S. Air Force, the U.S. Marine Corps, and the U.S. Army from Medevac to strategic critical care airlift missions worldwide.
The Propaq M is equipped with the complete advanced Masimo® rainbow® SET® technology, including total hemoglobin (SpHb®) and pleth variability index (PVI®) along with advanced physiologic monitoring with three integrated invasive blood pressure channels. The Propaq M offers robust data communication and remote viewing capabilities. This remote viewing capability, currently installed on the USNS Comfort and USNS Mercy, has been instrumental in recent humanitarian missions to the Caribbean, Central America, and Asia Pacific regions of the world.
The Propaq M now joins several other ZOLL airworthy products selected by the services as their standard critical care transport medical devices including:
- The Propaq MD ultra-lightweight, airworthy monitor/defibrillator that provides advanced monitoring capabilities, including full Masimo® Rainbow® SET technology and data transmission capabilities
- The EMV+® 731 Series portable transport ventilator designed specifically for the U.S. military
- The 330 Aspirator, the next generation in “smart” airworthy aspirators
- The SMEED™ critical care platform designed to secure ZOLL monitors, monitor defibrillators, ventilators, and aspirators to standard NATO litters.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the material, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
©2018 ZOLL Medical Corporation. All rights reserved. EMV+, SMEED, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. Propaq is a registered trademark of Welch Allyn. Masimo, PVI, rainbow, SET, and SpHb are trademarks or registered trademarks of Masimo Corporation. All other trademarks are the property of their respective owners.
ZOLL Medical Corporation
Diane Egan, +1-978-421-9637
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Cryptos Fund, a Quasi-ETF, Is Now Open to Investors23.1.2018 09:00 | Pressemelding
Cryptos Fund allows investors to gain exposure to Cryptocurrencies with reduced risk in a regulated environment. Cryptos Fund is the brainchild of a team of leading academics, quants and security experts based in Zug, Switzerland. It is designed to passively track the CCI30 index (www.cci30.com), an indicator of cryptocurrencies valuations and the benchmark for the sector. Carlo Scevola, one of the fund’s principals, says: “Cryptos Fund was initially created as a private investment vehicle. I first bought Bitcoin in 2011, and when its value became substantial I wanted to diversify into other cryptocurrencies with a rigorous scientific approach. There was no suitable option available, so I created my own fund.” Cryptos Fund is also a response to heavy investor demand: “It bridges the gap between the traditional financial system and the cryptocurrencies sector. Investors need to participate in the cryptocurrency market via a regulated entity, which didn’t exist until now.” Cryptos Fund i
HYCM Launches Ripple and Bitcoin Cash Cryptocurrency CFDs23.1.2018 08:48 | Pressemelding
HYCM, a multi-regulated global leader in online capital markets trading, has launched trading on two additional cryptocurrencies, Ripple and Bitcoin Cash, adding XRP/USD and BCH/USD to its range of cryptocurrency offerings. The decision to add Ripple and Bitcoin Cash to its existing crypto offerings, Bitcoin, Litecoin and Ethereum, follows the continued increase in demand from investors in the wake of the recent cryptocurrency boom. HYCM thus now offers 24/5 leveraged trading on the most volatile virtual currencies coupled with low spreads and competitive margins. Ripple (XRP) is both a transaction network and crypto token which was created in 2012 as the go-to cryptocurrency for banks and global money transfers, and has recently experienced a period of growth. Bitcoin Cash (BCH) meanwhile, is a blockchain derived from the Bitcoin blockchain which followed the split of Bitcoin (hard fork) in August 2017. Bitcoin Cash has also recently experienced gains as investors seek to diversify th
ADOIT 8.3 Unboxed: BOC Group Releases the Next Version of Its Professional EA Suite23.1.2018 08:00 | Pressemelding
BOC Group is happy to present the next release of ADOIT. Powerful workflow capabilities to manage ever-changing Enterprise Architectures are one, yet not the only, highlight of ADOIT 8.3. BOC Group, an internationally leading vendor and manufacturer of software tools for globally recognized management approaches introduces the next evolution of its powerful 100% web-based EA suite. ADOIT steps out of the box and delivers valuable insights that are easily digested by decision makers through its powerful aggregated views. The EA suite enables to quickly launch Enterprise Architecture and IT Management initiatives and start turning buried or hidden information into business value with easy analysis, just a few clicks away. In the course of delivering more than 1,000 implementation projects worldwide, BOC Group has acquired extensive experience that has benefited ADOIT's development significantly. With the new workflow capabilities and release state filter options in ADOIT 8.3, on top of o
21st Century Fox Welcomes the CMA’s Provisional Finding on Company’s Genuine Commitment to Broadcasting Standards23.1.2018 07:29 | Pressemelding
21st Century Fox notes today’s publication by the Competition and Markets Authority (CMA) of its Provisional Findings Report regarding the Company’s proposed acquisition of the remaining shares in Sky. Today’s provisional findings move our proposed Sky transaction forward to the next phase of the regulatory review process. We welcome the CMA’s provisional finding that the Company has a genuine commitment to broadcasting standards and the transaction would not be against the public interest in this respect. Regarding plurality, we are disappointed by the CMA’s provisional findings. We will continue to engage with the CMA ahead of the publication of the final report in May. We also note that the CMA has elected to avail itself of the statutory 8-week extension, moving its deadline for a final decision to May 1, 2018. We anticipate regulatory approval of the transaction by June 30, 2018. About 21st Century Fox 21st Century Fox is one of the world's leading portfolios of cable, broadcast,
IDEMIA Announces Acquisition of Otono Networks and Its eSIM Orchestration Solution23.1.2018 06:30 | Pressemelding
IDEMIA, the global leader in Augmented Identity for an increasingly digital world, today announced the acquisition of Otono Networks and its industry-leading eSIM orchestration technology. Together, IDEMIA and Otono will offer a comprehensive eSIM lifecycle management solution to simplify the adoption of eSIM for both mobile operators (MNOs) and device manufacturers (OEMs). This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180122006566/en/ This acquisition marks the first external expansion by the IDEMIA group, formed in 2017 when OT (Oberthur Technologies) and Safran Identity & Security (Morpho) joined forces, and illustrates IDEMIA’s strategic vision facing the future of connected devices. By 2020, connected objects in use worldwide could reach 20.4 billion (source: www.gartner.com). Faced with the increasing number of new eSIM devices (smartphones, smartwatches, tablets, PCs, etc.) and IoT applications, MNOs and OEMs must con
Takeda Recognized as a Global 100 Most Sustainable Corporation for Third Consecutive Year23.1.2018 06:30 | Pressemelding
Takeda Pharmaceutical Company Limited [TOKYO:4502], (“Takeda”) is proud to be named by Corporate Knights as one of the 2018 Global 100 Most Sustainable Corporations in the World (Global 100) for the third consecutive year. This distinction is based on 17 key performance indicators including financial management, clean revenue, and supplier performance. Takeda performed in the top 25% on innovation capacity, receiving notable recognition for its leadership diversity. Global 100 companies in 2018 represent the top 1.3% in the world on sustainability performance. The Index launched in 2005; results are disclosed annually at the World Economic Forum in Davos. As a LEAD company within the United Nations Global Compact, Takeda’s established track record in sustainability is guided by long-term international targets such as the Sustainable Development Goals (SDGs). Takeda is the only Japanese pharmaceutical company and among the four companies from Japan to make the final 100 in 2018, and one
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom